These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
723 related items for PubMed ID: 23902838
1. [Change and significance of urinary smad3 in type 2 diabetic nephropathy]. Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB. Zhonghua Yi Xue Za Zhi; 2013 Apr 09; 93(14):1067-71. PubMed ID: 23902838 [Abstract] [Full Text] [Related]
2. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Wang QY, Chen FQ. Diabetes Res Clin Pract; 2009 Feb 09; 83(2):215-9. PubMed ID: 19097668 [Abstract] [Full Text] [Related]
3. Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy. Guo K, Lu J, Kou J, Wu M, Zhang L, Yu H, Zhang M, Bao Y, Chen H, Jia W. BMC Nephrol; 2015 Oct 08; 16():159. PubMed ID: 26449625 [Abstract] [Full Text] [Related]
4. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus. Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Diabet Med; 2004 Jun 08; 21(6):545-51. PubMed ID: 15154937 [Abstract] [Full Text] [Related]
5. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Lu B, Wen J, Song XY, Dong XH, Yang YH, Zhang ZY, Zhao NQ, Ye HY, Mou B, Chen FL, Liu Y, Shen Y, Wang XC, Zhou LN, Li YM, Zhu XX, Hu RM. Diabetes Res Clin Pract; 2007 Feb 08; 75(2):184-92. PubMed ID: 16893584 [Abstract] [Full Text] [Related]
6. [Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients]. Zhou Y, Guo LX, Yu DN, Zhou L, Wang Y, Mou ZQ, Wang XX, Zhang LN, Li M. Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jun 08; 33(6):610-3. PubMed ID: 22883271 [Abstract] [Full Text] [Related]
7. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y. Diabetes Metab Res Rev; 2009 Mar 08; 25(3):232-41. PubMed ID: 19177462 [Abstract] [Full Text] [Related]
8. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study. Bessa SS, Hussein TA, Morad MA, Amer AM. Ren Fail; 2012 Mar 08; 34(6):670-5. PubMed ID: 22486214 [Abstract] [Full Text] [Related]
9. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy. Li Q, Feng L, Li J, Chen Q. Endocrine; 2014 May 08; 46(1):83-9. PubMed ID: 23943254 [Abstract] [Full Text] [Related]
10. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH. Cardiovasc Diabetol; 2016 Jan 07; 15():3. PubMed ID: 26739836 [Abstract] [Full Text] [Related]
11. Effect of exercise on albuminuria in people with diabetes. Koh KH, Dayanath B, Doery JC, Polkinghorne KR, Teede H, Kerr PG. Nephrology (Carlton); 2011 Nov 07; 16(8):704-9. PubMed ID: 21854502 [Abstract] [Full Text] [Related]
12. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus. Cha DR, Kim IS, Kang YS, Han SY, Han KH, Shin C, Ji YH, Kim NH. Diabet Med; 2005 Jan 07; 22(1):14-20. PubMed ID: 15606685 [Abstract] [Full Text] [Related]
13. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria]. Mayaudon H, Bauduceau B, Ducorps M, Belmejdoub G, Poirier JM. Arch Mal Coeur Vaiss; 1996 Aug 07; 89(8):1045-9. PubMed ID: 8949376 [Abstract] [Full Text] [Related]
14. [Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes]. Fu WJ, Zheng L, Wang Q, Deng RT, Ye CQ, Wang SB, Peng LF, Xiong SL, Tang HH. Nan Fang Yi Ke Da Xue Xue Bao; 2011 May 07; 31(5):878-81. PubMed ID: 21602148 [Abstract] [Full Text] [Related]
15. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes. Viana LV, Gross JL, Camargo JL, Zelmanovitz T, da Costa Rocha EP, Azevedo MJ. J Diabetes Complications; 2012 May 07; 26(5):407-12. PubMed ID: 22677793 [Abstract] [Full Text] [Related]
16. Increased leptin concentrations and lack of gender difference in Type 2 diabetic patients with nephropathy. Chan WB, Ma RC, Chan NN, Ng MC, Lee ZS, Lai CW, Tong PC, So WY, Chan JC. Diabetes Res Clin Pract; 2004 May 07; 64(2):93-8. PubMed ID: 15063601 [Abstract] [Full Text] [Related]
17. The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio. Ma X, Lu C, Lv C, Wu C, Wang Q. J Diabetes Res; 2016 May 07; 2016():6789402. PubMed ID: 26881255 [Abstract] [Full Text] [Related]
18. Familial factors in diabetic nephropathy: an offspring study. Agius E, Attard G, Shakespeare L, Clark P, Vidya MA, Hattersley AT, Fava S. Diabet Med; 2006 Mar 07; 23(3):331-4. PubMed ID: 16492220 [Abstract] [Full Text] [Related]
19. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus. Elsheikh M, Elhefnawy KA, Emad G, Ismail M, Borai M. J Bras Nefrol; 2019 Mar 07; 41(4):509-517. PubMed ID: 30897192 [Abstract] [Full Text] [Related]
20. Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes. Li Q, Gong W, Yang Z, Lu B, Yang Y, Zhao W, Hu R. Diabetes Res Clin Pract; 2013 Jun 07; 100(3):385-90. PubMed ID: 23602322 [Abstract] [Full Text] [Related] Page: [Next] [New Search]